Back to List View Graph View

COVID-19 vaccine

The COVID-19 vaccine is a pharmaceutical intervention designed to elicit an immune response against the severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2), the virus responsible for the COVID-19 pandemic.

1 paper landed today · 16 Nov 2026
  • Surveillance of adverse events following immunisation in Australia, 2024. PMID 43035019

Where the papers sit

32 papers from the last 6 months study COVID-19 vaccine directly

Those 32 are all about one subject.

  • COVID-19 Vaccination Outcomes

    Real-world vaccination research centers on safety surveillance, uptake, access and population benefit. Monitoring covers reactogenicity and uncommon events, including vulvar ulcers and postmenopausal bleeding, while population studies assess mortality after vaccine introduction. Persistent gaps involve racial, geographic and socioeconomic inequities in confidence and access, especially among older adults, youth and rural communities. Economic evaluations and implementation studies support broad coverage, convenient delivery and community-engaged communication.

    32 papers

NEW DIRECTION

A hypothetical combination influenza/COVID-19 vaccine is treated as a pharmacy workflow intervention

The U.S. pharmacy-setting study of a hypothetical combination influenza/COVID-19 vaccine found that replacing separate vaccinations could improve workflow efficiency through reduced preparation, administration, documentation, and insurance-related work 43001902Nov. The vaccine is therefore assigned a role beyond preventing infection or influencing uptake: it becomes an operational tool for reorganizing vaccine delivery.

Papers

The 32 papers from the last 6 months that study COVID-19 vaccine directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

COVID-19 Vaccination Outcomes (32)
  1. Surveillance of adverse events following immunisation in Australia, 2024. Communicable diseases intelligence (2018) · 15 Nov 2026 PMID 43035019
  2. Pharmacists' perspectives on efficiencies and other benefits of combination influenza/COVID-19 vaccination. Journal of medical economics · 9 Nov 2026 PMID 43001902
  3. Global return-on-investment of COVID-19 vaccines in the first year of the vaccination programme: A model-based economic evaluation. PLoS medicine · 5 Nov 2026 PMID 42986802
  4. Association Between Acute Vulvar Ulcers and Gene-Based COVID-19 Vaccines. Taiwanese journal of obstetrics & gynecology · 28 Oct 2026 PMID 42951458
  5. Postmenopausal Bleeding Risk after COVID-19 Vaccination: A Population-Based Self-Controlled Case Series Study. Yonsei medical journal · 27 Oct 2026 PMID 42937145
  6. Mobile-app-based cohort event monitoring study (CEM) of COVID-19 vaccines. Vaccine · 7 Oct 2026 PMID 42843285
  7. Ethnic disparities in COVID-19 vaccine uptake among among 55+ year-old Canadians: Exploring the role of racial discrimination, chronic disease comorbidities, and conspiracy beliefs. Vaccine · 6 Oct 2026 PMID 42837895
  8. Predictors of COVID-19 vaccination status among youth in eThekwini, South Africa: results from the AYAZAZI RIGHTS study. Global health action · 6 Oct 2026 PMID 42834877
  9. Positive emotions and credibility: Understanding how a community-engaged online campaign featuring clinician testimonials improved rural vaccine promotion. Social science & medicine (1982) · 5 Oct 2026 PMID 42833101
  10. Perception of COVID-19 vaccine effectiveness perception in older racialized communities: role of major racial discrimination and health literacy. Vaccine · 5 Oct 2026 PMID 42832932
  11. Real-world evaluation of 2023-2024 XBB.1.5 mRNA and protein-based COVID-19 vaccine reactogenicity from the randomized BEEHIVE trial. Human vaccines & immunotherapeutics · 30 Sept 2026 PMID 42811742
  12. Payers should cover COVID-19 vaccines for all ages and risk groups with no patient cost sharing. Journal of managed care & specialty pharmacy · 29 Sept 2026 PMID 42808541
  13. Availability and accessibility of SARS-CoV-2 vaccines among rural populations in sub-Saharan Africa: a systematic review and meta-analysis protocol. BMJ open · 24 Sept 2026 PMID 42785944
  14. Sociodemographic and Lifestyle Factors Associated With COVID-19 Vaccine Uptake in a Mixed Urban-Rural Population in Eastern Poland. Medical science monitor : international medical journal of experimental and clinical research · 23 Sept 2026 PMID 42776929
  15. COVID-19 mortality risk among people with HIV in Florida before and after the introduction of COVID-19 vaccines: A population-based study. PloS one · 18 Sept 2026 PMID 42758717
  16. Are both COVID-19 and COVID-19 vaccines associated with cancer? Oncotarget · 11 Sept 2026 PMID 42725534
  17. The Relationship Between Political Affiliation, Perceptions of Science and Scientists, and Perceived Safety and Effectiveness of the MMR, Flu, and COVID-19 Vaccines: United States, 2024. American journal of public health · 10 Sept 2026 PMID 42721425
  18. Gaps between willingness and uptake of influenza and COVID-19 vaccines during the 2025-26 respiratory virus season in a U.S. adult cohort. Vaccine · 6 Sept 2026 PMID 42702142
  19. The platform trial in COVID-19 priming and BOOsting (PICOBOO): The reactogenicity of nine licensed COVID-19 vaccines delivered in immunocompetent adults. Vaccine · 5 Sept 2026 PMID 42700749
  20. A cohort study to assess the safety and coverage of COVID-19, influenza, and pertussis vaccine in Australian pregnant women. Vaccine · 29 Aug 2026 PMID 42667899
  21. Effectiveness of coronavirus disease 2019 (COVID-19) original vaccines to prevent COVID-19-related hospitalisations among Alaska Native peoples, January 2021-October 2022. International journal of circumpolar health · 22 Aug 2026 PMID 42632078
  22. Lessons learnt from one-year cold chain support for COVID-19 vaccination in 5 middle income countries of North Africa. Vaccine · 18 Aug 2026 PMID 42612463
  23. COVID-19 vaccination among people affected by sexually transmitted and bloodborne infections, methamphetamine use and their intersection in Manitoba, Canada: a retrospective matched cohort analysis using population-based administrative healthcare data (2020-2022). BMJ open · 12 Aug 2026 PMID 42586735
  24. Why COVID-19 vaccination struggled in the Democratic Republic of Congo: a qualitative study exploring organizational and sociocultural barriers, 2025. Vaccine · 12 Aug 2026 PMID 42585810
  25. Healthy vaccinee effect in the evaluation of updated COVID-19 vaccines in elderly populations. Nature communications · 8 Aug 2026 PMID 42570961
  26. Partisan differences in healthcare decision-making: Evidence from a vaccine experiment. PloS one · 20 Jul 2026 PMID 42475322
  27. The Relationship Between COVID-19 Vaccine Regret, Distrust of the Healthcare System, and Future Vaccine Intentions. Journal of evaluation in clinical practice · 19 Jul 2026 PMID 42472384
  28. Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024. Vaccine · 2 Jul 2026 PMID 42391690
  29. V-safe: Summary of findings reported after COVID-19 vaccination to a US CDC active safety surveillance system through June 2023. Vaccine · 30 Jun 2026 PMID 42378925
  30. Caregiver COVID-19 vaccine status and its influence on pediatric vaccination decisions in a US cohort. Vaccine · 17 Jun 2026 PMID 42308977
  31. Partisan and Geographic Variation in Emotional Responses to COVID-19 Vaccination on Social Media. JAMA network open · 1 Jun 2026 PMID 42223941
  32. Online Information Behavior Regarding COVID-19 Vaccination and Its Association With Vaccination Behavior Based on Cluster Analysis of User Groups: Cross-Sectional Study. JMIR infodemiology · 29 May 2026 PMID 42214069

By study type

Clinical trials (3)
  1. Positive emotions and credibility: Understanding how a community-engaged online campaign featuring clinician testimonials improved rural vaccine promotion. Social science & medicine (1982) · 5 Oct 2026 PMID 42833101
  2. Real-world evaluation of 2023-2024 XBB.1.5 mRNA and protein-based COVID-19 vaccine reactogenicity from the randomized BEEHIVE trial. Human vaccines & immunotherapeutics · 30 Sept 2026 PMID 42811742
  3. The platform trial in COVID-19 priming and BOOsting (PICOBOO): The reactogenicity of nine licensed COVID-19 vaccines delivered in immunocompetent adults. Vaccine · 5 Sept 2026 PMID 42700749
Observational studies and case reports (15)
  1. Pharmacists' perspectives on efficiencies and other benefits of combination influenza/COVID-19 vaccination. Journal of medical economics · 9 Nov 2026 PMID 43001902
  2. Association Between Acute Vulvar Ulcers and Gene-Based COVID-19 Vaccines. Taiwanese journal of obstetrics & gynecology · 28 Oct 2026 PMID 42951458
  3. Mobile-app-based cohort event monitoring study (CEM) of COVID-19 vaccines. Vaccine · 7 Oct 2026 PMID 42843285
  4. Ethnic disparities in COVID-19 vaccine uptake among among 55+ year-old Canadians: Exploring the role of racial discrimination, chronic disease comorbidities, and conspiracy beliefs. Vaccine · 6 Oct 2026 PMID 42837895
  5. Predictors of COVID-19 vaccination status among youth in eThekwini, South Africa: results from the AYAZAZI RIGHTS study. Global health action · 6 Oct 2026 PMID 42834877
  6. Perception of COVID-19 vaccine effectiveness perception in older racialized communities: role of major racial discrimination and health literacy. Vaccine · 5 Oct 2026 PMID 42832932
  7. Sociodemographic and Lifestyle Factors Associated With COVID-19 Vaccine Uptake in a Mixed Urban-Rural Population in Eastern Poland. Medical science monitor : international medical journal of experimental and clinical research · 23 Sept 2026 PMID 42776929
  8. Gaps between willingness and uptake of influenza and COVID-19 vaccines during the 2025-26 respiratory virus season in a U.S. adult cohort. Vaccine · 6 Sept 2026 PMID 42702142
  9. A cohort study to assess the safety and coverage of COVID-19, influenza, and pertussis vaccine in Australian pregnant women. Vaccine · 29 Aug 2026 PMID 42667899
  10. Effectiveness of coronavirus disease 2019 (COVID-19) original vaccines to prevent COVID-19-related hospitalisations among Alaska Native peoples, January 2021-October 2022. International journal of circumpolar health · 22 Aug 2026 PMID 42632078
  11. COVID-19 vaccination among people affected by sexually transmitted and bloodborne infections, methamphetamine use and their intersection in Manitoba, Canada: a retrospective matched cohort analysis using population-based administrative healthcare data (2020-2022). BMJ open · 12 Aug 2026 PMID 42586735
  12. The Relationship Between COVID-19 Vaccine Regret, Distrust of the Healthcare System, and Future Vaccine Intentions. Journal of evaluation in clinical practice · 19 Jul 2026 PMID 42472384
  13. Caregiver COVID-19 vaccine status and its influence on pediatric vaccination decisions in a US cohort. Vaccine · 17 Jun 2026 PMID 42308977
  14. Partisan and Geographic Variation in Emotional Responses to COVID-19 Vaccination on Social Media. JAMA network open · 1 Jun 2026 PMID 42223941
  15. Online Information Behavior Regarding COVID-19 Vaccination and Its Association With Vaccination Behavior Based on Cluster Analysis of User Groups: Cross-Sectional Study. JMIR infodemiology · 29 May 2026 PMID 42214069
Human data, design not indexed (14)
  1. Surveillance of adverse events following immunisation in Australia, 2024. Communicable diseases intelligence (2018) · 15 Nov 2026 PMID 43035019
  2. Global return-on-investment of COVID-19 vaccines in the first year of the vaccination programme: A model-based economic evaluation. PLoS medicine · 5 Nov 2026 PMID 42986802
  3. Postmenopausal Bleeding Risk after COVID-19 Vaccination: A Population-Based Self-Controlled Case Series Study. Yonsei medical journal · 27 Oct 2026 PMID 42937145
  4. Payers should cover COVID-19 vaccines for all ages and risk groups with no patient cost sharing. Journal of managed care & specialty pharmacy · 29 Sept 2026 PMID 42808541
  5. Availability and accessibility of SARS-CoV-2 vaccines among rural populations in sub-Saharan Africa: a systematic review and meta-analysis protocol. BMJ open · 24 Sept 2026 PMID 42785944
  6. COVID-19 mortality risk among people with HIV in Florida before and after the introduction of COVID-19 vaccines: A population-based study. PloS one · 18 Sept 2026 PMID 42758717
  7. Are both COVID-19 and COVID-19 vaccines associated with cancer? Oncotarget · 11 Sept 2026 PMID 42725534
  8. The Relationship Between Political Affiliation, Perceptions of Science and Scientists, and Perceived Safety and Effectiveness of the MMR, Flu, and COVID-19 Vaccines: United States, 2024. American journal of public health · 10 Sept 2026 PMID 42721425
  9. Lessons learnt from one-year cold chain support for COVID-19 vaccination in 5 middle income countries of North Africa. Vaccine · 18 Aug 2026 PMID 42612463
  10. Why COVID-19 vaccination struggled in the Democratic Republic of Congo: a qualitative study exploring organizational and sociocultural barriers, 2025. Vaccine · 12 Aug 2026 PMID 42585810
  11. Healthy vaccinee effect in the evaluation of updated COVID-19 vaccines in elderly populations. Nature communications · 8 Aug 2026 PMID 42570961
  12. Partisan differences in healthcare decision-making: Evidence from a vaccine experiment. PloS one · 20 Jul 2026 PMID 42475322
  13. Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024. Vaccine · 2 Jul 2026 PMID 42391690
  14. V-safe: Summary of findings reported after COVID-19 vaccination to a US CDC active safety surveillance system through June 2023. Vaccine · 30 Jun 2026 PMID 42378925